Home > Boards > US Listed > Medical - Drugs > The Medicines Company (MDCO)

News: $MDCO The Medicines Company Announces that the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 57
Posts 7,158
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 12/10/2019 9:44:57 AM
Schedule 13g Edgar (US Regulatory) - 12/9/2019 11:06:37 AM
Statement of Ownership: Solicitation (sc 14d9) Edgar (US Regulatory) - 12/5/2019 8:02:22 AM
Tender Offer Statement by Third Party (sc To-t) Edgar (US Regulatory) - 12/5/2019 7:59:30 AM
WeissLaw LLP Investigates The Medicines Co. PR Newswire (US) - 11/26/2019 5:26:00 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 11/26/2019 4:34:21 PM
Written Communication Relating to an Issuer or Third Party (sc To-c) Edgar (US Regulatory) - 11/25/2019 4:54:08 PM
Rowley Law PLLC is Investigating Proposed Acquisition of The Medicines Company PR Newswire (US) - 11/25/2019 2:21:00 PM
The Medicines Co. Shares Up 23% on Novartis Buyout Offer Dow Jones News - 11/25/2019 10:09:00 AM
(MDCO) Alert: Johnson Fistel Investigates Proposed Sale of The Medicines Company; Is $85 a Fair Price? PR Newswire (US) - 11/25/2019 8:41:00 AM
Written Communication Relating to an Issuer or Third Party (sc To-c) Edgar (US Regulatory) - 11/25/2019 7:33:27 AM
Statement of Ownership: Solicitation (sc 14d9) Edgar (US Regulatory) - 11/25/2019 6:39:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2019 6:36:30 AM
Novartis Expands Its Push Into Heart Drugs -- WSJ Dow Jones News - 11/25/2019 3:02:00 AM
Novartis to Buy Drugmaker The Medicines Co. --2nd Update Dow Jones News - 11/24/2019 6:34:00 PM
The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion Business Wire - 11/24/2019 3:05:00 PM
Medicines Co. Shares Up 19% After Bloomberg Report Dow Jones News - 11/19/2019 11:16:00 AM
Medicines Co. Shares Up 26% After Bloomberg Report Dow Jones News - 11/19/2019 8:57:00 AM
The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable & Potent LDL-C Lowering ... Business Wire - 11/18/2019 9:00:00 AM
The Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable & Potent Lowering of L... Business Wire - 11/16/2019 10:45:00 AM
The Medicines Company to Present Inclisiran Data from ORION-9 & ORION-10 Pivotal Phase 3 Clinical Studies at American Heart A... Business Wire - 11/6/2019 4:30:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/30/2019 4:52:57 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2019 7:19:26 AM
The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran Business Wire - 10/30/2019 7:00:00 AM
The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30 Business Wire - 10/24/2019 4:30:00 PM
whytestocks Member Level  Monday, 11/18/19 02:45:23 PM
Re: None
Post # of 231 
News: $MDCO The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing

- Inclisiran achieved 50% LDL-C lowering with time-adjusted reductions of 45% sustained over 18 months of treatment in patients with heterozygous familial hypercholesterolemia (HeFH) - ORION-9 further demonstrated inclisiran’s excellent safety profile, including no treatment-relate...

In case you are interested MDCO - The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist